Moleculin Biotech’s (NASDAQ:MBRX) lock-up period is set to expire on Tuesday, November 29th. Moleculin Biotech had issued 1,540,026 shares in its public offering on June 2nd. The total size of the offering was $9,240,156 based on an initial share price of $6.00. After the expiration of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Moleculin Biotech (NASDAQ:MBRX) opened at 2.9999 on Monday. The company’s market capitalization is $36.16 million. The stock has a 50 day moving average of $3.24 and a 200 day moving average of $5.62. Moleculin Biotech has a 12 month low of $2.34 and a 12 month high of $9.58.
Moleculin Biotech Company Profile